Chicago 2025 China Summit Successfully Concludes: Chinese Research Shines on ASCO Stage, Resonating with the Global Oncology Community

2025-6-6
阅读全文
GHG Medical Team to Present Three Innovative Studies at ASCO 2025

2025-5-22
阅读全文
EHA 2025 | GoBroad Medical Team Presents 24 Research Achievements on the Global Stage! Multi-Dimensional Innovations Break Therapeutic Boundaries and Enhance Patient Survival

2025-5-15
阅读全文
Pioneering the introduction of groundbreaking medications, offering renewed hope to patients with relapse or refractory tumors.

2025-3-4
阅读全文
Breaking Through Drug Resistance! Beijing GoBroad Hospital has Issued the First Prescription for Taletrectinib in Beijing, Bringing Renewed Hope for Advanced Lung Cancer Patients

2025-2-22
阅读全文
China Pharmaceutical University and GoBroad Healthcare Group Establish the "Institute of Statistical Science" to Advance Biopharmaceutical Research and Clinical Innovation

2025-2-13
阅读全文
The "Beijing Key Laboratory of Cell and Gene Therapy for Solid Tumors" headed by Prof. Shen Lin was successfully approved.

2025-2-7
阅读全文
Successfully Passed the Review! Beijing GoBroad Hospital Has Obtained the Qualification for Clinical Application of Lu-177 Radionuclide Therapy

2024-12-10
阅读全文
ASH2024丨17 achievements of GoBroad medical team highlight the international academic stage!

2024-11-1
阅读全文

血液系统疾病诊疗

实体肿瘤诊疗

优势诊疗技术

就诊指南

邮箱：international.service@gobroadhealthcare.com

电话：+86-010-50951957

地址：北京市丰台区丽泽金融商务区丽泽路20号丽泽SOHO南塔12层

扫码关注我们

北京高博医疗科技集团有限公司京公网安备 11010502037763号京ICP备19005517号-3

联系我们

邮箱：international.service@gobroadhealthcare.com

电话：+86-010-50951957

地址：北京市丰台区丽泽金融商务区丽泽路20号丽泽SOHO南塔12层

扫码关注我们

北京高博医疗科技集团有限公司京公网安备 11010502037763号京ICP备19005517号-3